Maryland SB 759: Health - Prescription Drug Affordability Board

Status: Favorable with Amendments Report by Health and Government Operations (as of 2019-04-08)

State: Maryland · Session: 2019 · Bill: SB 759

Subjects: Public Health, Insurance - Health, Advertising, Appeals, Assessments, Attorney General, Auditors and Audits, Budgets, Commerce and Business, Committees and Commissions, Communications, Comptroller, Consumer Protection, Consumer Price Index, Contracts, Data, Demographics, Disclosure, Drugs, Ethics, Examinations, Federal Government, Fees, Health, Health Care Commission, Health Insurance, Health Services Cost Review Commission, Industry and Technology, Information Technology, Department of, Investigations and Inquiries, Labeling, Medical Treatments, Medical Research, Minorities, Notices, Open Government, Patients, Pharmacy Benefits Managers, Prices, Privacy, Procurement, Publications, Public Information, Records, Reimbursement Rates, Reports, Retail Sales, Revenue and Taxes, Rules and Regulations, Salaries and Compensation, Social Services, Tax Returns, Telecommunications and Information Technology, Time, Treasurers, Voting, Weights and Measures, Witnesses, Work, Labor and Employment

Sponsors: Klausmeier and Lam

View Maryland SB 759 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.